AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
_6ff029a61766633234293.png?format=webp&width=1186&height=250)
Amplifon drops as much as 26.9% after earnings guidance
ByAinvest
Wednesday, Jul 30, 2025 3:37 am ET1min read
Amplifon drops as much as 26.9% after earnings guidance
Italian hearing aid company Amplifon (AMPF.MI) saw its shares drop by as much as 26.9% on Tuesday following the release of its second-quarter 2025 earnings report. The company reported a 8.7% decline in core profit to 147.3 million euros ($169.84 million) on revenue that rose by 0.6% [1].Amplifon's CEO, Enrico Vita, attributed the challenging market conditions to the company's performance in core markets such as Southern Europe, North America, and China. Despite this, Vita noted that operations in France and Germany performed in line with expectations [1].
The company also lowered its guidance for 2025, projecting consolidated revenue growth of about 3% compared to the previously expected mid-to-high single-digit percentage. Additionally, the forecast for its adjusted core profit margin was reduced to about 23% from a previous projection of 24% [1].
Amplifon's revenue growth was impacted by a 1.9% decrease at current exchange rates due to euro appreciation, while organic growth was negative at -1.7% in Q2. The company's adjusted EBITDA margin decreased by 180 basis points year-over-year, primarily due to lower operating leverage and an unfavorable geographic mix [3].
The company anticipates a gradual improvement in market conditions in the second half of the year, particularly in Europe and the US. However, the Southern European markets were negatively affected by the anniversary of the strict COVID lockdowns in 2020, impacting the customer base. The Chinese market also continued to show subdued trends, and the Australian market experienced a negative trend [3].
Amplifon's shares were trading at a significant discount compared to its peers, with the stock dropping to 2.24 euros from 3.07 euros at the start of the year. The stock's performance was negatively affected by the company's guidance miss and the broader market conditions [2].
References:
[1] https://www.reuters.com/en/italys-amplifon-reports-87-decline-second-quarter-core-profit-lowers-2025-2025-07-29/
[2] https://www.benzinga.com/markets/market-summary/25/07/46698073/crude-oil-gains-over-1-unitedhealth-earnings-miss-views
[3] https://finance.yahoo.com/news/amplifon-spa-amfpf-q2-2025-071545230.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet